Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News BVA and SVS raise concerns over sheep anthelmintic reclassification

BVA and SVS raise concerns over sheep anthelmintic reclassification

31st August 2017

The British Veterinary Association (BVA) and Sheep Veterinary Society (SVS) have voiced their misgivings about the recent reclassification of an anthelmintic for sheep.

Concerns have been raised over the Veterinary Medicines Directorate's decision to reclassify Startect Dual Active Oral Solution – designed for the treatment of mixed gastrointestinal nematode infections and associated diseases – from POM-V to POM-VPS status.

It means that pharmacists and suitably qualified persons will now be able to prescribe the drug as well as vets, at a time when resistance to anthelmintics is increasing in grazing animals worldwide.

The BVA and SVS are concerned that the reclassification is in direct opposition to the strategy in Europe of increasing control over the dispensing of anthelmintics among species where resistance is posing a serious threat.

John Fishwick, junior vice-president of the BVA, said: "The BVA believes that the prescribing of anthelmintics requires a level of control best provided by a veterinary surgeon who has the animals under his/her care, and is based on a sound clinical diagnosis."

With over 20 years of experience within the animal health market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current animal health roles we have available, you can search for the latest job roles, register your details, or contact the team today.ADNFCR-8000103-ID-801839487-ADNFCR

We have hundreds of jobs available across the Healthcare industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.